Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japa
Phase 2
Recruiting
- Conditions
- Esophageal cancerD000077277
- Registration Number
- JPRN-jRCTs031210002
- Lead Sponsor
- Watanabe Akinori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
protocol
Exclusion Criteria
protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method